Correlation Between Samsung Biologics and PanGen Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and PanGen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and PanGen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Biologics Co and PanGen Biotech, you can compare the effects of market volatilities on Samsung Biologics and PanGen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of PanGen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and PanGen Biotech.

Diversification Opportunities for Samsung Biologics and PanGen Biotech

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Samsung and PanGen is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and PanGen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PanGen Biotech and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with PanGen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PanGen Biotech has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and PanGen Biotech go up and down completely randomly.

Pair Corralation between Samsung Biologics and PanGen Biotech

Assuming the 90 days trading horizon Samsung Biologics Co is expected to under-perform the PanGen Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Samsung Biologics Co is 3.98 times less risky than PanGen Biotech. The stock trades about -0.13 of its potential returns per unit of risk. The PanGen Biotech is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  490,000  in PanGen Biotech on August 30, 2024 and sell it today you would earn a total of  110,000  from holding PanGen Biotech or generate 22.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Samsung Biologics Co  vs.  PanGen Biotech

 Performance 
       Timeline  
Samsung Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Samsung Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Samsung Biologics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
PanGen Biotech 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PanGen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, PanGen Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Samsung Biologics and PanGen Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Samsung Biologics and PanGen Biotech

The main advantage of trading using opposite Samsung Biologics and PanGen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, PanGen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PanGen Biotech will offset losses from the drop in PanGen Biotech's long position.
The idea behind Samsung Biologics Co and PanGen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital